0

Close
 
Upcoming Allied Market Research
2023
Asia Pacific Computerized Physician Order Entry Market

Asia Pacific Computerized Physician Order Entry Market

- Opportunities and Forecasts, 2023-2030

LS : Pharmaceuticals
Report Code: A00702
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Asia Pacific Computerized Physician Order Entry Market

Request Now !

Computerized physician order entry is a process of entering prescription and an information about medical services into computer systems by medical practitioners. This information is communicated to medical staff and other departments through a computer network. Faster transfer of prescription to other departments, electronic records of prescription, clinical decision support systems, and economic efficiency are benefits of computerized physician order entry system over traditional hand-written or verbally communicated methods. The system is gaining prominence due to reduction the errors, such as poor handwriting in ordering and transcribing medicines to the patients.

Supportive government policies, rising demand of efficient healthcare IT systems, large population base, increasing incidences of chronic incidences are the driving factors of the Asian computerized physician order entry market. The emerging economies, such as India create opportunities for growth of this market.

The Asian computerized physician order entry market is segmented into type, component, deployment, end user, and geography. Based on type, the market is classified into standalone and integrated. The market is divided into hardware, software, and services. On the basis of deployment, the market is classified into on-premise, web-based, and cloud-based systems. The end user segment includes, office-based physician, emergency healthcare service providers, hospitals, and nurses. The market is segmented geographically into Japan, China, India, and Rest of Asia (RoA).

The key market players profiled in this report are Allscripts, Cerner Corporation, Athenahealth, Carestream Health Inc., Epic Systems, eClinicalWorks LLC, McKesson Corporation, GE Healthcare, Practice Fusion, Philips Healthcare, and Siemens Healthcare AG. These players implement various strategies, such as mergers & acquisitions, partnerships, new product launches, and investments to gain strong foothold in market.

KEY BENEFITS FOR STAKEHOLDERS:

  • The report offers an in-depth analysis of current and future market trends of the Asian computerized physician order entry market.
  • The report offers a detailed analysis of key driving and restraining factors of the Asian computerized physician order entry market.
  • This report offers an in-depth quantitative analysis of the current market and estimations which assists in identifying the prevailing opportunities.
  • The key manufacturers within the Asian computerized physician order entry market are profiled in the report and their strategies are analyzed thoroughly.
  • An extensive analysis of dominant segment of the market helps in understanding the current market.
  • The report provides insights on new technologies, research & development activities and new product launches.
  • Geographically, the market is segmented into China, Japan, India, and Rest of the Asia (RoA).

 Asia Pacific Computerized Physician Order Entry Market Report Highlights

Aspects Details
By Type
  • Standalone
  • Integrated
By Component
  • Hardware
  • Software
  • Services
By Deployment
  • On-premise
  • Web-based
  • Cloud-based
By End User
  • Office-based physician
  • Emergency healthcare service providers
  • Hospitals
  • Nurses
By Geography
  • China
  • Japan
  • India
  • Rest of Asia (RoA)
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.4. Market Share Analysis/Top Player Positioning

      • 3.4.1. Market Share Analysis/Top Player Positioning 2021

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Standalone

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Integrated

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET, BY COMPONENT

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Component

    • 5.2. Hardware

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Software

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Services

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET, BY DEPLOYMENT

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Deployment

    • 6.2. On-premise

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Web-based

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Cloud-based

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Office-based Physician

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Emergency Healthcare Service Providers

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Hospitals

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Nurses

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. China

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Type

      • 8.2.3. Market Size and Forecast, By Component

      • 8.2.4. Market Size and Forecast, By Deployment

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.3. Japan

        • 8.3.1. Key Market Trends and Opportunities

        • 8.3.2. Market Size and Forecast, By Type

        • 8.3.3. Market Size and Forecast, By Component

        • 8.3.4. Market Size and Forecast, By Deployment

        • 8.3.5. Market Size and Forecast, By End User

        • 8.3.6. Market Size and Forecast, By Country

        • 8.4. India

          • 8.4.1. Key Market Trends and Opportunities

          • 8.4.2. Market Size and Forecast, By Type

          • 8.4.3. Market Size and Forecast, By Component

          • 8.4.4. Market Size and Forecast, By Deployment

          • 8.4.5. Market Size and Forecast, By End User

          • 8.4.6. Market Size and Forecast, By Country

          • 8.5. Rest Of Asia (RoA)

            • 8.5.1. Key Market Trends and Opportunities

            • 8.5.2. Market Size and Forecast, By Type

            • 8.5.3. Market Size and Forecast, By Component

            • 8.5.4. Market Size and Forecast, By Deployment

            • 8.5.5. Market Size and Forecast, By End User

            • 8.5.6. Market Size and Forecast, By Country

          • CHAPTER 9: COMPANY PROFILES

            • 9.1. Company 1

              • 9.1.1. Company Overview

              • 9.1.2. Key Executives

              • 9.1.3. Company Snapshot

              • 9.1.4. Operating Business Segments

              • 9.1.5. Product Portfolio

              • 9.1.6. Business Performance

              • 9.1.7. Key Strategic Moves and Developments

            • 9.2. Company 2

              • 9.2.1. Company Overview

              • 9.2.2. Key Executives

              • 9.2.3. Company Snapshot

              • 9.2.4. Operating Business Segments

              • 9.2.5. Product Portfolio

              • 9.2.6. Business Performance

              • 9.2.7. Key Strategic Moves and Developments

            • 9.3. Company 3

              • 9.3.1. Company Overview

              • 9.3.2. Key Executives

              • 9.3.3. Company Snapshot

              • 9.3.4. Operating Business Segments

              • 9.3.5. Product Portfolio

              • 9.3.6. Business Performance

              • 9.3.7. Key Strategic Moves and Developments

            • 9.4. Company 4

              • 9.4.1. Company Overview

              • 9.4.2. Key Executives

              • 9.4.3. Company Snapshot

              • 9.4.4. Operating Business Segments

              • 9.4.5. Product Portfolio

              • 9.4.6. Business Performance

              • 9.4.7. Key Strategic Moves and Developments

            • 9.5. Company 5

              • 9.5.1. Company Overview

              • 9.5.2. Key Executives

              • 9.5.3. Company Snapshot

              • 9.5.4. Operating Business Segments

              • 9.5.5. Product Portfolio

              • 9.5.6. Business Performance

              • 9.5.7. Key Strategic Moves and Developments

            • 9.6. Company 6

              • 9.6.1. Company Overview

              • 9.6.2. Key Executives

              • 9.6.3. Company Snapshot

              • 9.6.4. Operating Business Segments

              • 9.6.5. Product Portfolio

              • 9.6.6. Business Performance

              • 9.6.7. Key Strategic Moves and Developments

            • 9.7. Company 7

              • 9.7.1. Company Overview

              • 9.7.2. Key Executives

              • 9.7.3. Company Snapshot

              • 9.7.4. Operating Business Segments

              • 9.7.5. Product Portfolio

              • 9.7.6. Business Performance

              • 9.7.7. Key Strategic Moves and Developments

            • 9.8. Company 8

              • 9.8.1. Company Overview

              • 9.8.2. Key Executives

              • 9.8.3. Company Snapshot

              • 9.8.4. Operating Business Segments

              • 9.8.5. Product Portfolio

              • 9.8.6. Business Performance

              • 9.8.7. Key Strategic Moves and Developments

            • 9.9. Company 9

              • 9.9.1. Company Overview

              • 9.9.2. Key Executives

              • 9.9.3. Company Snapshot

              • 9.9.4. Operating Business Segments

              • 9.9.5. Product Portfolio

              • 9.9.6. Business Performance

              • 9.9.7. Key Strategic Moves and Developments

            • 9.10. Company 10

              • 9.10.1. Company Overview

              • 9.10.2. Key Executives

              • 9.10.3. Company Snapshot

              • 9.10.4. Operating Business Segments

              • 9.10.5. Product Portfolio

              • 9.10.6. Business Performance

              • 9.10.7. Key Strategic Moves and Developments

          • LIST OF TABLES

          • TABLE 1. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
          • TABLE 2. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR STANDALONE, BY REGION, 2021-2031 ($MILLION)
          • TABLE 3. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR INTEGRATED, BY REGION, 2021-2031 ($MILLION)
          • TABLE 4. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET, BY COMPONENT, 2021-2031 ($MILLION)
          • TABLE 5. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
          • TABLE 6. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
          • TABLE 7. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
          • TABLE 8. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
          • TABLE 9. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR ON-PREMISE, BY REGION, 2021-2031 ($MILLION)
          • TABLE 10. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR WEB-BASED, BY REGION, 2021-2031 ($MILLION)
          • TABLE 11. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR CLOUD-BASED, BY REGION, 2021-2031 ($MILLION)
          • TABLE 12. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET, BY END USER, 2021-2031 ($MILLION)
          • TABLE 13. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR OFFICE-BASED PHYSICIAN, BY REGION, 2021-2031 ($MILLION)
          • TABLE 14. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR EMERGENCY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
          • TABLE 15. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
          • TABLE 16. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR NURSES, BY REGION, 2021-2031 ($MILLION)
          • TABLE 17. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET, BY REGION, 2021-2031 ($MILLION)
          • TABLE 18. CHINA ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY REGION, 2021-2031 ($MILLION)
          • TABLE 19. CHINA ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY TYPE, 2021-2031 ($MILLION)
          • TABLE 20. CHINA ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY COMPONENT, 2021-2031 ($MILLION)
          • TABLE 21. CHINA ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY DEPLOYMENT, 2021-2031 ($MILLION)
          • TABLE 22. CHINA ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY END USER, 2021-2031 ($MILLION)
          • TABLE 23. JAPAN ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY REGION, 2021-2031 ($MILLION)
          • TABLE 24. JAPAN ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY TYPE, 2021-2031 ($MILLION)
          • TABLE 25. JAPAN ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY COMPONENT, 2021-2031 ($MILLION)
          • TABLE 26. JAPAN ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY DEPLOYMENT, 2021-2031 ($MILLION)
          • TABLE 27. JAPAN ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY END USER, 2021-2031 ($MILLION)
          • TABLE 28. INDIA ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY REGION, 2021-2031 ($MILLION)
          • TABLE 29. INDIA ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY TYPE, 2021-2031 ($MILLION)
          • TABLE 30. INDIA ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY COMPONENT, 2021-2031 ($MILLION)
          • TABLE 31. INDIA ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY DEPLOYMENT, 2021-2031 ($MILLION)
          • TABLE 32. INDIA ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY END USER, 2021-2031 ($MILLION)
          • TABLE 33. REST OF ASIA (ROA) ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY REGION, 2021-2031 ($MILLION)
          • TABLE 34. REST OF ASIA (ROA) ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY TYPE, 2021-2031 ($MILLION)
          • TABLE 35. REST OF ASIA (ROA) ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY COMPONENT, 2021-2031 ($MILLION)
          • TABLE 36. REST OF ASIA (ROA) ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY DEPLOYMENT, 2021-2031 ($MILLION)
          • TABLE 37. REST OF ASIA (ROA) ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY, BY END USER, 2021-2031 ($MILLION)
          • TABLE 38. COMPANY 1: KEY EXECUTIVES
          • TABLE 39. COMPANY 1: COMPANY SNAPSHOT
          • TABLE 40. COMPANY 1: OPERATING SEGMENTS
          • TABLE 41. COMPANY 1: PRODUCT PORTFOLIO
          • TABLE 42. COMPANY 1: KEY STRATEGIC MOVES AND DEVELOPMENTS
          • TABLE 43. COMPANY 2: KEY EXECUTIVES
          • TABLE 44. COMPANY 2: COMPANY SNAPSHOT
          • TABLE 45. COMPANY 2: OPERATING SEGMENTS
          • TABLE 46. COMPANY 2: PRODUCT PORTFOLIO
          • TABLE 47. COMPANY 2: KEY STRATEGIC MOVES AND DEVELOPMENTS
          • TABLE 48. COMPANY 3: KEY EXECUTIVES
          • TABLE 49. COMPANY 3: COMPANY SNAPSHOT
          • TABLE 50. COMPANY 3: OPERATING SEGMENTS
          • TABLE 51. COMPANY 3: PRODUCT PORTFOLIO
          • TABLE 52. COMPANY 3: KEY STRATEGIC MOVES AND DEVELOPMENTS
          • TABLE 53. COMPANY 4: KEY EXECUTIVES
          • TABLE 54. COMPANY 4: COMPANY SNAPSHOT
          • TABLE 55. COMPANY 4: OPERATING SEGMENTS
          • TABLE 56. COMPANY 4: PRODUCT PORTFOLIO
          • TABLE 57. COMPANY 4: KEY STRATEGIC MOVES AND DEVELOPMENTS
          • TABLE 58. COMPANY 5: KEY EXECUTIVES
          • TABLE 59. COMPANY 5: COMPANY SNAPSHOT
          • TABLE 60. COMPANY 5: OPERATING SEGMENTS
          • TABLE 61. COMPANY 5: PRODUCT PORTFOLIO
          • TABLE 62. COMPANY 5: KEY STRATEGIC MOVES AND DEVELOPMENTS
          • TABLE 63. COMPANY 6: KEY EXECUTIVES
          • TABLE 64. COMPANY 6: COMPANY SNAPSHOT
          • TABLE 65. COMPANY 6: OPERATING SEGMENTS
          • TABLE 66. COMPANY 6: PRODUCT PORTFOLIO
          • TABLE 67. COMPANY 6: KEY STRATEGIC MOVES AND DEVELOPMENTS
          • TABLE 68. COMPANY 7: KEY EXECUTIVES
          • TABLE 69. COMPANY 7: COMPANY SNAPSHOT
          • TABLE 70. COMPANY 7: OPERATING SEGMENTS
          • TABLE 71. COMPANY 7: PRODUCT PORTFOLIO
          • TABLE 72. COMPANY 7: KEY STRATEGIC MOVES AND DEVELOPMENTS
          • TABLE 73. COMPANY 8: KEY EXECUTIVES
          • TABLE 74. COMPANY 8: COMPANY SNAPSHOT
          • TABLE 75. COMPANY 8: OPERATING SEGMENTS
          • TABLE 76. COMPANY 8: PRODUCT PORTFOLIO
          • TABLE 77. COMPANY 8: KEY STRATEGIC MOVES AND DEVELOPMENTS
          • TABLE 78. COMPANY 9: KEY EXECUTIVES
          • TABLE 79. COMPANY 9: COMPANY SNAPSHOT
          • TABLE 80. COMPANY 9: OPERATING SEGMENTS
          • TABLE 81. COMPANY 9: PRODUCT PORTFOLIO
          • TABLE 82. COMPANY 9: KEY STRATEGIC MOVES AND DEVELOPMENTS
          • TABLE 83. COMPANY 10: KEY EXECUTIVES
          • TABLE 84. COMPANY 10: COMPANY SNAPSHOT
          • TABLE 85. COMPANY 10: OPERATING SEGMENTS
          • TABLE 86. COMPANY 10: PRODUCT PORTFOLIO
          • TABLE 87. COMPANY 10: KEY STRATEGIC MOVES AND DEVELOPMENTS

          • LIST OF FIGURES

          • FIGURE 1. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET SEGMENTATION
          • FIGURE 2. GLOBAL ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET
          • FIGURE 3. SEGMENTATION ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET
          • FIGURE 4. TOP INVESTMENT POCKET IN ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET
          • FIGURE 5. TOP WINNING STRATEGIES, 2019-2021*
          • FIGURE 6. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021*(%)
          • FIGURE 7. TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
          • FIGURE 8. MODERATE BARGAINING POWER OF BUYERS
          • FIGURE 9. MODERATE BARGAINING POWER OF SUPPLIERS
          • FIGURE 10. MODERATE THREAT OF NEW ENTRANTS
          • FIGURE 11. LOW THREAT OF SUBSTITUTION
          • FIGURE 12. HIGH COMPETITIVE RIVALRY
          • FIGURE 13. TOP PLAYER POSITIONING, 2021
          • FIGURE 14. MARKET SHARE ANALYSIS, 2021
          • FIGURE 15. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET
          • FIGURE 16. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET SEGMENTATION, BY BY TYPE
          • FIGURE 17. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR STANDALONE, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 18. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR INTEGRATED, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 19. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET SEGMENTATION, BY BY COMPONENT
          • FIGURE 20. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR HARDWARE, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 21. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR SOFTWARE, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 22. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 23. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET SEGMENTATION, BY BY DEPLOYMENT
          • FIGURE 24. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR ON-PREMISE, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 25. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR WEB-BASED, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 26. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR CLOUD-BASED, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 27. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET SEGMENTATION, BY BY END USER
          • FIGURE 28. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR OFFICE-BASED PHYSICIAN, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 29. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR EMERGENCY HEALTHCARE SERVICE PROVIDERS, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 30. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 31. ASIA PACIFIC COMPUTERIZED PHYSICIAN ORDER ENTRY MARKET FOR NURSES, BY COUNTRY, 2021-2031 ($MILLION)
          • FIGURE 32. COMPANY 1: NET SALES, 2019-2021 ($MILLION)
          • FIGURE 33. COMPANY 1: REVENUE SHARE, BY SEGMENT, 2031 (%)
          • FIGURE 34. COMPANY 1: REVENUE SHARE, BY REGION, 2031 (%)
          • FIGURE 35. COMPANY 2: NET SALES, 2019-2021 ($MILLION)
          • FIGURE 36. COMPANY 2: REVENUE SHARE, BY SEGMENT, 2031 (%)
          • FIGURE 37. COMPANY 2: REVENUE SHARE, BY REGION, 2031 (%)
          • FIGURE 38. COMPANY 3: NET SALES, 2019-2021 ($MILLION)
          • FIGURE 39. COMPANY 3: REVENUE SHARE, BY SEGMENT, 2031 (%)
          • FIGURE 40. COMPANY 3: REVENUE SHARE, BY REGION, 2031 (%)
          • FIGURE 41. COMPANY 4: NET SALES, 2019-2021 ($MILLION)
          • FIGURE 42. COMPANY 4: REVENUE SHARE, BY SEGMENT, 2031 (%)
          • FIGURE 43. COMPANY 4: REVENUE SHARE, BY REGION, 2031 (%)
          • FIGURE 44. COMPANY 5: NET SALES, 2019-2021 ($MILLION)
          • FIGURE 45. COMPANY 5: REVENUE SHARE, BY SEGMENT, 2031 (%)
          • FIGURE 46. COMPANY 5: REVENUE SHARE, BY REGION, 2031 (%)
          • FIGURE 47. COMPANY 6: NET SALES, 2019-2021 ($MILLION)
          • FIGURE 48. COMPANY 6: REVENUE SHARE, BY SEGMENT, 2031 (%)
          • FIGURE 49. COMPANY 6: REVENUE SHARE, BY REGION, 2031 (%)
          • FIGURE 50. COMPANY 7: NET SALES, 2019-2021 ($MILLION)
          • FIGURE 51. COMPANY 7: REVENUE SHARE, BY SEGMENT, 2031 (%)
          • FIGURE 52. COMPANY 7: REVENUE SHARE, BY REGION, 2031 (%)
          • FIGURE 53. COMPANY 8: NET SALES, 2019-2021 ($MILLION)
          • FIGURE 54. COMPANY 8: REVENUE SHARE, BY SEGMENT, 2031 (%)
          • FIGURE 55. COMPANY 8: REVENUE SHARE, BY REGION, 2031 (%)
          • FIGURE 56. COMPANY 9: NET SALES, 2019-2021 ($MILLION)
          • FIGURE 57. COMPANY 9: REVENUE SHARE, BY SEGMENT, 2031 (%)
          • FIGURE 58. COMPANY 9: REVENUE SHARE, BY REGION, 2031 (%)
          • FIGURE 59. COMPANY 10: NET SALES, 2019-2021 ($MILLION)
          • FIGURE 60. COMPANY 10: REVENUE SHARE, BY SEGMENT, 2031 (%)
          • FIGURE 61. COMPANY 10: REVENUE SHARE, BY REGION, 2031 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Asia Pacific Computerized Physician Order Entry Market

Start reading.
This Report and over 68,226+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $2,850
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $2,670
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $4,740
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $5,830
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers